Long-term efficacy and safety of larotrectinib in patients with TRK fusion primary central nervous system (CNS) tumors: An updated analysis Meeting Abstract


Authors: Perreault, S.; Spano, J. P.; Nilsson, A.; Deyell, R. J.; Doz, F.; Geoerger, B.; Gumus, M.; Lassen, U. N.; Nysom, K.; Valero-Arrese, L.; Idbaih, A.; Bernard-Gauthier, V.; Neu, N.; Brega, N.; Drilon, A.; Laetsch, T. W.; van Tilburg, C. M.
Abstract Title: Long-term efficacy and safety of larotrectinib in patients with TRK fusion primary central nervous system (CNS) tumors: An updated analysis
Meeting Title: 29th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO)
Journal Title: Neuro-Oncology
Volume: 26
Issue: Suppl. 8
Meeting Dates: 2024 Nov 21-24
Meeting Location: Houston, TX
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2024-11-01
Start Page: viii95
End Page: viii96
Language: English
ACCESSION: WOS:001362632500032
DOI: 10.1093/neuonc/noae165.0375
PROVIDER: wos
Notes: Meeting Abstract: CTNI-07 (Citation ID: NOAE165.0375) -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon